The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line therapy with fulvestrant (FUL) in HR+ve, HER2-ve advanced pre-treated breast cancer (ABC) patients (pts): Results from the GIM-13 AMBRA Study.
 
Paolo Pronzato
Honoraria - Amgen; Celgene; Pfizer; Roche
Travel, Accommodations, Expenses - Celgene; Novartis; Roche
 
Giorgio Mustacchi
Honoraria - Celgene
Consulting or Advisory Role - Celgene
Travel, Accommodations, Expenses - Celgene; Roche
 
Monica Giordano
Travel, Accommodations, Expenses - Janssen; Roche
 
Ornella Garrone
Research Funding - Eisai
 
Lucia Del Mastro
No Relationships to Disclose
 
Clara Natoli
No Relationships to Disclose
 
Anna Turletti
Travel, Accommodations, Expenses - Eisai; Pierre Fabre; Roche; Teva
 
Emanuela Romagnoli
No Relationships to Disclose
 
Alessandra Bologna
No Relationships to Disclose
 
Carmela Mocerino
No Relationships to Disclose
 
Massimiliano Alù
No Relationships to Disclose
 
Claudia De Angelis
No Relationships to Disclose
 
Caterina Aversa
No Relationships to Disclose
 
Grazia Arpino
Honoraria - GlaxoSmithKline; Ipsen; Novartis; Roche
Consulting or Advisory Role - Celgene; Eisai; Ipsen; Lilly; Novartis; Pfizer; Roche
Research Funding - Eisai; Novartis; Roche
Travel, Accommodations, Expenses - Eisai; GlaxoSmithKline; Lilly; Novartis; Pfizer; Roche
 
Cristiana Taverniti
No Relationships to Disclose
 
Laura Biganzoli
Honoraria - AstraZeneca; Celgene; Pfizer; Pierre Fabre; Takeda
Consulting or Advisory Role - AstraZeneca; Eisai; Lilly; Novartis; Pfizer; Puma Biotechnology; Roche
Research Funding - Celgene (Inst)
Travel, Accommodations, Expenses - Ipsen
 
Icro Meattini
No Relationships to Disclose
 
Michela Piezzo
No Relationships to Disclose
 
Marina Elena Cazzaniga
Consulting or Advisory Role - Celgene; Novartis; Pierre Fabre; Roche
Speakers' Bureau - Celgene; Pierre Fabre
Travel, Accommodations, Expenses - Celgene